Search

AMED’s HealthTech Challenge supported early-stage infectious-disease technology projects at Japanese institutions, including startup or entrepreneurship-oriented academic work. The 2025 call closed at noon on September 11. Support was stage

The Asia-Pacific call supported small-scale action research combining climate mitigation/adaptation with reduced antimicrobial use and AMR mitigation in livestock or aquaculture. Up to four studies were planned, with a stated total budget o

Phage Team Uganda announced a workshop on capacity building for phage research and applications against AMR in human, animal, crop and environmental health, at Hilton Garden Inn, Kampala. Hilton Garden Inn, Kampala, Uganda Phage Team Uganda

Quadram Institute seeks a part-time Project Coordinator (0.5–0.8 FTE, 18 months) to support the Food Safety Research Network (FSRN) and the UKRI-funded AMR in Agrifood Systems Transdisciplinary Network (AMAST): administering funding calls,

The WHO Bacteriophage Community of Practice held its inaugural webinar, bringing together participants from all six WHO regions to discuss phage-based approaches to antimicrobial resistance. The recap links to a recording through the Commun

SAAFE PhD scholars join research partners working on antimicrobial-resistance monitoring, analytics and solutions. Support includes a A$45,000 annual scholarship for 3.5 years FTE and a A$21,000 professional-development fund. Candidates can

PhageLand was designed to combine phage-based treatment with constructed wetlands to reduce the spread of antibiotic resistance from wastewater into surface waters. Its stated project period was February 2022 to January 2025. PhageLand

Scheduled for July 3, 2025 at the Royal Society’s Summer Science Exhibition, Franklin Nobrega’s talk “Fighting superbugs with tiny warriors” was advertised as an in-person talk with a livestream. Royal Society — exact talk programme

DELGEME Plus offered a fully funded MSc fellowship in antimicrobial resistance at USTTB in Bamako, Mali. Support covered stipend, limited research costs, travel and training. Class 2 applications closed on September 30, 2024. DELGEME Plus

CARB-X’s next Expression of Interest window is scheduled for November 10, 2026 at 10:00 ET through November 23 at 23:59 ET. The 2026 funding round lists four themes: Gram-negative therapeutics, novel target-based chemistry, non-vaccine neon

A Clinical Infectious Diseases case series screened Mycobacterium isolates from 200 patients for phage susceptibility and gave phages intravenously, by aerosolization or both to 20 patients on a compassionate-use basis. No adverse reactions

The UKRI–Southeast Asia call supported collaborative infectious-disease research with antimicrobial-resistance and epidemic potential. UKRI offered up to £1 million per project, with partner-country funding rules set separately. Application

The 2026 OH-TREAT call supports transnational antimicrobial-resistance research. Pre-proposals closed on February 2; invited full proposals closed on June 17, 2026. Participating funders apply their own national eligibility and funding rule

The Hooper Shaw Foundation-funded scholarship supports full-time PhD research on bacteriophage-based antimicrobial biotechnology in Sydney’s Faculty of Medicine and Health. It provides the university RTP stipend rate for up to 3.5 years, su

C-CAMP’s second environmental-AMR call offered up to £170,000 or approximately ₹2 crore per startup or innovation, with mentoring and validation support. Indian innovators could apply; non-Indian applicants needed an Indian subsidiary or pa

African early/mid-career scientists could apply for six months of training in Italy, India or South Africa, with host-specific stipends, travel, insurance and visa support. Topics include AMR, pathogen biology and computational biology/AI.

ICBRAR 2026 is scheduled for November 3–4 in Hisar, with a November 1–2 pre-conference workshop. Registration deadline: October 15, 2026 — Late registration deadline; fee section also says valid till 1st Oct 2026.. Submission deadline: Oc

The University of Salford (supervisor Prof. Chloe James) seeks a candidate for an MPhil project exploring a targeted bacteriophage-based mouthwash: isolating and characterising bacteriophages from pooled waste collected during routine denta

Rhea Coler's lab at Seattle Children's develops bacteriophage therapies for tuberculosis, nontuberculous mycobacterial infections and cystic fibrosis lung disease, working with Graham Hatfull's lab at the University of Pittsburgh with Gates

CDC's May 2023 update on the multistate outbreak of extensively drug-resistant VIM-GES-CRPA Pseudomonas aeruginosa associated with artificial tears reports 81 patients in 18 states as of May 15, 2023. It notes that phages with activity agai